HeartWare International Acquires Valtech Cardio, Ltd.

September 2015

Adds Comprehensive Suite of Surgical and Transcatheter Mitral and Tricuspid Valve Repair and Replacement Technologies to the HeartWare Portfolio

HeartWare International Acquires Valtech Cardio, Ltd.

HeartWare International Acquires Valtech Cardio, Ltd.

Adds Comprehensive Suite of Surgical and Transcatheter Mitral and Tricuspid Valve Repair and Replacement Technologies to the HeartWare Portfolio

Sept. 1, 2015. HeartWare International, Inc. (HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd. ("Valtech").  Valtech is a privately held company that specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases – mitral valve regurgitation (MR) and tricuspid valve regurgitation (TR).

« Go back